Vincerx Pharma, Inc. Common Stock (VINC) — Financial Flexibility Index
Vincerx Pharma, Inc. Common Stock (VINC) has a Financial Flexibility Index of -1.70x as of March 2025. Free cash flow of $-4.45 Million (operating CF $-4.45 Million minus capex $0.00) represents -2% of total liabilities ($2.62 Million). Check Vincerx Pharma, Inc. Common Stock (VINC) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vincerx Pharma, Inc. Common Stock Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Vincerx Pharma, Inc. Common Stock across 6 annual periods. See how liquid is Vincerx Pharma, Inc. Common Stock's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vincerx Pharma, Inc. Common Stock (2019–2024)
Year-by-year free cash flow to debt coverage for Vincerx Pharma, Inc. Common Stock. For the full company profile including market capitalisation, see market value of Vincerx Pharma, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.95x | $-26.13 Million | $-26.13 Million | $5.28 Million | ▲ +14.5% |
| 2023 | -5.78x | $-40.45 Million | $-40.45 Million | $7.00 Million | ▼ -12.7% |
| 2022 | -5.13x | $-59.60 Million | $-59.60 Million | $11.62 Million | ▼ -216.4% |
| 2021 | -1.62x | $-28.14 Million | $-33.40 Million | $17.36 Million | ▼ -341.7% |
| 2020 | -0.37x | $-2.02 Million | $-2.28 Million | $5.50 Million | ▼ -107.2% |
| 2019 | 5.07x | $223.00K | $-35.00K | $44.00K | — |